Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
27 July 2023 - 9:00PM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose
mission is to develop medicines that meaningfully improve and
extend the lives of patients facing deadly diseases, today
announced that it will host a live conference call and audio
webcast on Thursday, August 3, 2023 at 8:30 a.m. ET to report
financial results for the second quarter ended June 30, 2023, and
to provide a business overview.
To access the live conference call, please dial
(646) 307-1963 (domestic) or (800) 715-9871 (international) at
least five minutes prior to the start time, and refer to conference
ID 8015897. A live audio webcast of the call will also be available
on the Investors’ section of the Company's website,
www.chimerix.com. An archived webcast will be available on the
Chimerix website approximately two hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company with a
mission to develop medicines that meaningfully improve and extend
the lives of patients facing deadly diseases. The Company’s most
advanced clinical-stage development program, ONC201, is in
development for H3 K27M-mutant glioma.
CONTACTS:
Michelle LaSpaluto919 972-7115ir@chimerix.com
Will O’ConnorStern Investor
Relations212-362-1200will@sternir.com
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Jul 2023 to Jul 2024